title: The influence of oseltamivir treatment on the risk of stroke after influenza infection.
abstract: OBJECTIVE
  It was the aim of this study to examine the influence of the antiviral medication oseltamivir on stroke and transient ischemic attack (TIA) in adults diagnosed with influenza.
  
  
  METHODS
  This retrospective cohort study used medical and pharmaceutical claims data from May 2000 to September 2006 from an administrative claims database. Episodes of stroke/TIA in the 6 months after influenza in adults (aged > or =18 years) prescribed oseltamivir within 1 day before or 2 days after influenza diagnosis (oseltamivir cohort), and adults prescribed no antivirals (comparison cohort) were compared using multivariate analyses adjusted for demographic and clinical risk factors.
  
  
  RESULTS
  The oseltamivir cohort comprised 49,238 patients and the comparison cohort 102,692 patients. Oseltamivir was associated with a 28% reduction in risk of stroke/TIA in the 6 months after influenza [hazard ratio (HR) 0.72; 95% CI 0.62-0.82] and with significant reductions after 1 and 3 months. In patients <65 years of age, there was a 34% risk reduction with oseltamivir after 6 months (HR 0.66; 95% CI 0.56-0.77) and also significant reductions after 1 and 3 months. In those aged > or =65 years, there was a 51% reduction in risk after 1 month (HR 0.49; 95% CI 0.27-0.91).
  
  
  CONCLUSIONS
  Prescription of oseltamivir for influenza is associated with a reduced risk of stroke/TIA.
authors.affiliation: Texas Heart Institute, 6770 Bertner Ave., MC 2-255, Houston, TX 77030, USA. Mohammad.Madjid@uth.tmc.edu
authors.forename: Mohammad
authors.initials: M
authors.lastname: Madjid
authors.forename: Suellen
authors.initials: S
authors.lastname: Curkendall
authors.forename: William A
authors.initials: WA
authors.lastname: Blumentals
mesh_terms: D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000008:administration & dosage*; D015897:Comorbidity; D016208:Databases, Factual; D005260:Female; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D053139:Oseltamivir / Q000008:administration & dosage*; D012189:Retrospective Studies; D012307:Risk Factors; D040242:Risk Reduction Behavior; D020521:Stroke / Q000453:epidemiology* / Q000517:prevention & control*
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir